Protein Metrics

Executive Summary

Protein Metrics is a leading provider of vendor-neutral mass spectrometry data analysis software, specializing in protein characterization, quantification, and identification. Founded in 2010 and headquartered in Cupertino, California, the company serves biopharmaceutical and analytical laboratories with automated workflows that accelerate drug development. Its platform addresses critical needs in bioprocessing, including peptide mapping, intact protein analysis, and oligonucleotide characterization, all while maintaining compatibility with all major MS instrument vendors. By reducing manual data interpretation and increasing throughput, Protein Metrics helps clients shorten development timelines and improve product quality. The company's focus on AI/ML integration positions it at the forefront of the rapidly evolving proteomics market. The company's growth is driven by increasing demand for advanced analytics in biologics development and the shift toward more complex modalities like oligonucleotides. With a strong product-market fit and a loyal customer base among top biopharma firms, Protein Metrics is well-positioned to capitalize on the expansion of the proteomics software market, projected to grow at over 10% CAGR. However, competition from instrument vendors and open-source tools remains a risk. Overall, Protein Metrics offers a compelling investment opportunity in the digital transformation of biopharmaceutical R&D.

Upcoming Catalysts (preview)

• Q3 2026Launch of AI-enhanced de novo sequencing module80% success
• Q4 2026Strategic partnership with a top-10 biopharma for QC workflow integration65% success
• Q2 2026Series A funding round closure (estimated $15-20M)90% success